DNAJB1 and cancer: Inhibition of Hsp90 interactions plays a role in cancer therapy (Barrott and Haystead, 2013), and maintaining high levels of Hsp70/Hsp40 is thought to protect against aggregation diseases such as Huntington’s (Schaffar et al., 2004).